Mesa Verde Venture Partners

Mesa Verde Venture Partners focuses on investing in a diversified portfolio of early-stage biotechnology and medical technology companies.

Business Model:

Revenue: $3.8M

Employees: 2-10

Rankings

Detailed Mesa Verde Venture Partners Information

Geographic Data

Mesa Verde Venture Partners headquarters map

Address: 2550 5th Ave

City: San Diego

State: CA

Zip: 92103

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$5M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Mesa Verde Venture Partners focuses on investing in a diversified portfolio of early-stage biotechnology and medical technology companies. Its areas of focus include drug discovery/tools, medical devices and diagnostics, and healthcare information technology. The company was founded in 2006 and headquartered in San Diego, California.

Contact Phone:
+16192897428

Contact Email:

Announced Date Company Transaction Money Raised
2/2011 Exagen Venture Round 16.9M
9/2020 Immusoft Venture Round 0
11/2013 Exagen Debt Financing 25M
12/2019 Immix Biopharma Venture Round -
5/2011 Exagen Venture Round 5.4M
1/2017 Biscayne NeuroTherapeutics Series B 3M
1/2017 Biscayne Pharmaceuticals Series B 3M
8/2018 Paradigm Diagnostics Series B 0
6/2019 NeuraLace Medical Seed Round 0
5/2020 CalciMedica Series C 15M
9/2012 Exagen Series C 5.3M
12/2013 Lineagen Series C 0
1/2015 Lineagen Series C 0
11/2011 Lineagen Series B 0
1/2012 Elevation Pharmaceuticals Series B 0
9/2011 Elevation Pharmaceuticals Series A 0
12/2008 Lineagen Series A 5.8M
5/2019 Paradigm Diagnostics Series B 0
4/2009 Traversa Therapeutics Series B 5M
8/2010 Lineagen Series A 10.8M
6/2008 Medipacs Venture Round 1.6M
2/2011 Biomatrica Venture Round 1.2M
1/2010 Elevation Pharmaceuticals Series A 30M
1/2019 Immusoft Series B 0
9/2020 Immusoft Venture Round 0
5/2020 CalciMedica Series C 0
12/2019 Immix Biopharma Venture Round -
6/2019 NeuraLace Medical Seed Round 0
5/2019 Paradigm Diagnostics Series B 0
1/2019 Immusoft Series B 0
8/2018 Paradigm Diagnostics Series B 0
1/2017 Biscayne Pharmaceuticals Series B 0
1/2017 Biscayne NeuroTherapeutics Series B 0
1/2015 Lineagen Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research